NMPA China approves Clopidogrel Bisulfate API

Regulatory Product ApprovalBusiness Updates View source PDF

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-5.8%1-day move

₹174.50

prior close

₹177.39

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.6-1.0-0.6-1.1-5.8-14.3-10.9-13.5-15.2-14.4————

Up moveDown movePending

AI summary

IOL Chemicals has received approval from China's drug regulator NMPA for its API product Clopidogrel Bisulfate, used in blood-thinning medicines. This adds to the existing European CEP certification and opens direct access to the Chinese pharmaceutical market, strengthening the company's regulatory portfolio.

Likely market impact

Positive. China market access can drive new export revenue and adds a major geography to the company's API footprint beyond existing approvals.